Get started
Invesco Biotechnology & Genome ETFInvesco Biotechnology & Genome ETFInvesco Biotechnology & Genome ETF

Invesco Biotechnology & Genome ETF

No trades
See on Supercharts
Overview Chart Analysis
Holdings
News Ideas Discussions Technicals Seasonals Options

Invesco Biotechnology & Genome ETF holdings


As of August 8, 2025
Symbol
Weight %
Shares
Market value
A
ALNYAlnylam Pharmaceuticals, Inc
7.53%
‪‪38.48 K‬‬
‪‪16.89 M‬‬USD
R
RPRXRoyalty Pharma Plc Class A
5.72%
‪‪341.52 K‬‬
‪‪12.83 M‬‬USD
I
ILMNIllumina, Inc.
5.71%
‪‪135.34 K‬‬
‪‪12.80 M‬‬USD
G
GILDGilead Sciences, Inc.
5.45%
‪‪102.34 K‬‬
‪‪12.22 M‬‬USD
A
AMGNAmgen Inc.
5.14%
‪‪39.95 K‬‬
‪‪11.52 M‬‬USD
B
BMRNBioMarin Pharmaceutical Inc.
4.91%
‪‪192.13 K‬‬
‪‪11.01 M‬‬USD
U
UTHRUnited Therapeutics Corporation
4.77%
‪‪35.46 K‬‬
‪‪10.69 M‬‬USD
V
VRTXVertex Pharmaceuticals Incorporated
4.09%
‪‪25.03 K‬‬
‪‪9.17 M‬‬USD
A
AVXLAnavex Life Sciences Corp.
4.08%
‪‪826.28 K‬‬
‪‪9.16 M‬‬USD
I
INCYIncyte Corporation
3.26%
‪‪93.19 K‬‬
‪‪7.30 M‬‬USD
Get deeper insights with ETF data
Explore detailed ETF holdings data, including weight, shares, and market value.